Minimally invasive laser techniques for prostatectomy: A systematic review

BJU International

Volumn 86, Issue 7, 2000, Pages 805-815

  Wheelahan, J ^a   Scott, N A ^b   Cartmill, R ^c   Marshall, V ^d,h   Morton, R P ^e,h   Nacey, J ^f,i   Maddern, G J ^b,g,h,j  

^a Baringa Specialist Centre   (Australia)

^b ROYAL AUSTRALASIAN COLLEGE OF SURGEONS   (Australia)

^c Brisbane Urology Clinic   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

^e GREEN LANE HOSPITAL   (New Zealand)

^f WELLINGTON HOSPITAL   (New Zealand)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h Department of Surgery ^*

ⁱ UNIVERSITY OF OTAGO   (New Zealand)

^j ASERNIP S   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; HUMAN; LASER SURGERY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SURGICAL TECHNIQUE; VAPORIZATION; YAG LASER;

HUMANS; LASER COAGULATION; LASER SURGERY; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 0033757317     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00920.x     Document Type: Review

References (67)

1. Roehrborn CG, Issa MM, Bruskewitz RC et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology 1998; 51: 415-21
2. Holtgrewe HLU. Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology 1998; 51: 1-7
3. Jepsen J, Bruskewitz R. Recent developments in the surgical management of benign prostatic hyperplasia. Urology 1998; 51: 23-31
4. Mebust W. Holtgrewe H, Cockett A, Peters P, Writing Committee. Transurethral prostatectomy: Immediate post-operative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141: 243-7
5. Dunsmuir W, Emberton M, and The National Prostatectomy Audit Steering Group. There is significant sexual dysfunction following TURP. Br J Urol 1996; 77 (Suppl): 161A
6. Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate of benign prostatic hyperplasia. New Engl J Med 1989; 320: 1120
7. Holtgrewe H, Valk W. Factors influencing the mortality and morbidity of transurethral prostatectomy; a study of 2015 cases. J Urol 1962; 87: 450
8. Melchior J, Valk W, Foret J, Mebust W. Transurethral prostatectomy: computerised analysis of 2223 consecutive cases. J Urol 1974; 112: 632-42
9. Ansari M. Costello A, Jolley D, Ackland M, Carson N, McDonald I. Adverse events after prostatectomy in Victorian public hospitals. Aust NZ J Surg 1998; 68: 830-6
10. Bhatta K. Lasers in urology. Lasers Surg Med 1995; 16: 312-30
11. Stein BSU. Neodymium:yttrium-aluminum-garnet laser prostatectomy. Mayo Clin Proc 1998; 73: 787-91
12. Fitzpatrick JM. A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia. Br J Urol 1998; 81 (Suppl 1): 56-63
13. Chun S, Razvi H, Denstedt J. Laser prostatectomy with the holmium:YAG laser. Techniques Urol 1995; 1: 217-21
14. Milam D, Smith J. Laser prostatectomy devices and their tissue effects. J Endourol 1995; 9: 85-8
15. Boon TA, van-Swol CF, van-Venrooij GE, Beerlage HP, Verdaasdonk RM. Laser prostatectomy for patients with benign prostatic hyperplasia: a prospective randomised study comparing two different techniques using the Prolase-II fibre. World J Urol 1995; 13: 123-5
16. Dixon CM. Lasers for the treatment of benign prostatic hyperplasia. Urol Clin Nth Am 1995; 22: 413-22
17. te Slaa E, De La Rosette JJMCH. Lasers in the treatment of benign prostatic obstruction: Past, present and future. Eur Urol 1996; 30: 1-10
18. Schulze H. TULIP - transurethral ultrasound-guided laser-induced prostatectomy. World J Urol 1995; 13: 94-7
19. McCullough DL. Transurethral ultrasound-guided laser induced prostatectomy (TULIP) for the treatment of BPH. Semin Urol 1994; 12: 161-1
20. Keoghane SR, Cranston DW. A critical overview on the role of the Nd:YAG laser in the treatment of benign prostatic hypertrophy. Eur Urol 1994; 26: 193-6
21. Mottet N, Anidjar M. Bourdon O et al. Randomised comparison of transurethral electroresection and holmium:YAG laser vaporisation for symptomatic benign prostatic hyperplasia. J Endourol 1999; 13: 127-30
22. Portis A, Mador D. Treatment options for benign prostatic hyperplasia. Can Fam Physician 1997; 43: 1395-404
23. Watson G. Laser prostatectomy: where are we now, and where should we be going? J Endourol 1995; 9: 199-203
24. Muschter R, Hofstetter A. Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol 1995; 9: 129-35
25. Muschter R, Hofstetter A. Technique and results of interstitial laser coagulation. World J Urol 1995; 13: 109-14
26. Narayan P, Tewari A, Aboseif S. Evans C. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia. Urology 1995; 154: 2083-8
27. Horninger W, Janetschek G, Watson G, Reissigl A, Strasser H, Bartsch G. Are contact laser, interstitial laser, and transurethral ultrasound-guided laser-induced prostatectomy superior to transurethral prostatectomy? Prostate 1997; 31: 255-63
28. Erhard M, Bagley D. Urologic applications of the holmium laser: preliminary experience. J Endourol 1995; 9: 383-6
29. Larizgoitia I, Pons JMV. A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU Int 1999; 84: 1-9
30. Gilling PJ, Cass C, Cresswell MD, Malcolm A, Fraundorfer MR. The use of the holmium laser in the treatment of benign prostatic hyperplasia. J Endourol 1996; 10: 459-61
31. Wollin T, Denstedt J. The holmium laser in urology. J Clin Laser Med Surg 1998; 16: 13-20
32. Gilling PJ, Cass CB, Malcolm A, Cresswell M, Fraundorfer MR. Kabalin JN. Holmium laser resection of the prostate versus neodymium: yttrium-aluminium-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998; 51: 573-7
33. Jackson T, Street A, Costello A, Crowe H. Cost-effectiveness of laser ablation of the prostate: Premature evaluation. Int J Technol Assessment Health Care 1995; 11: 595-610
34. Suvakovic N, Hindmarsh JR. A step towards day case prostatectomy. Br J Urol 1996; 77: 212-4
35. Shingleton WB, Terrell F, Renfroe DL, Kolski J, Fowler JE. A randomised prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999; 54: 1017-21
36. Kollmorgen TA, Malek RS, Barrett DM. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology 1996; 48: 217-22
37. Carter A, Sells H, Speakman M, Ewings P, MacDonagh RP, O'Boyle P. A prospective randomised controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999; 83: 254-9
38. Le Duc A, Gilling PJ. Holmium laser resection of the prostate. Eur Urol 1999; 35: 155-60
39. Narayan P, Tewari A, Schalow E, Leidich R, Aboseif S, Cascione C. Transurethral vaporisation of the prostate for treatment of benign prostatic hyperplasia: Results in 168 patients with up to 12 months follow-up. J Urol 1997; 157: 1309-12
40. National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. Commonwealth of Australia, Canberra: 2000:56
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12
42. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd edn. New York: Wiley, 1981
43. Egger M, Smith GD, Phillips AN. Meta-analysis. Principles and procedures. BMJ 1997; 315: 1533-7
44. Cowles RS, Kabalin JN, Childs S et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995; 46: 155-60
45. Orihuela E, Motamedi M, Pow SM et al. Randomized clinical trial comparing low power-slow heating versus high power-rapid heating noncontact neodymium:yttrium-aluminum-garnet laser regimens for the treatment of benign prostatic hyperplasia. Urology 1995; 45: 783-9
46. Anson K, Nawrocki J, Buckley J et al. A multicenter. randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46: 305-10
47. Kabalin JN. Laser prostatectomy performed with a right angle firing neodymium:YAG laser fibre at 40 watts power setting. J Urol 1993; 150: 95-9
48. Kabalin JN, Gill HS, Bite G. Wolfe V, Mebust WK, McCullough DL. Comparative study of laser versus electro-cautery prostatic resection: 18-month followup with complex urodynamic assessment. Urology 1995; 153: 94-8
49. Uchida T, Egawa S. Iwamura M et al. A non-randomised comparative study of visual laser ablation and transurethral resection of the prostate in benign prostatic hyperplasia. Int J Urol 1995; 3: 108-12
50. Uchida T, Ohori M, Iwamura M et al. Visual laser ablation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia. Int J Urol 1996: 3 (Suppl 1): S55-S59
51. Chertin B, Moriel EZ. Hadas-Halperin I et al. Laser prostatectomy - long-term follow-up of 303 patients. Eur Urol 1999; 35: 285-8
52. Kingston E, Nonnenmacher AK, Crowe H, Costello AJ, Street A. Further evaluation of transurethral laser ablation of the prostate in patients treated with anticoagulant therapy. Aust NZ J Surg 1995; 65: 40-3
53. Kabalin JN, Gill HS, Bite G. Laser prostatectomy performed with a right-angle firing neodymium:YAG laser fibre at 60 watts power setting. J Urol 1995; 153: 1502-5
54. Kabalin JN, Gill HS, Leach GE, Bowers GW, Nill T, Konowalchuk TW. Prospective multicenter prolase II clinical trial of neodymium:yttrium-aluminum-garnet laser prostatectomy. Urology 1997; 50: 63-5
55. Daehlin L, Hedlund H. Interstitial laser coagulation in patients with lower urinary tract symptoms from benign prostatic obstruction: treatment under sedoanalgesia with pressure-flow evaluation. BJU Int 1999; 84: 628-36
56. Dixon CM. Evaluating the efficacy, safety, and cost of lasers for the treatment of benign prostatic hyperplasia. World J Urol 1995; 13: 130-3
57. Beerlage HP, Francisca EAE, D'Ancona FCH, Debruyne FMJ, De La Rosette JJMC. Urolase v Ultraline fibres in laser prostatectomy: 3-year follow-up of a randomised study. J Endourol 1998; 12: 575-80
58. De La Rosette JJMCH, Te SE, de-Wildt MJ, Debruyne FM. Experience with the Ultraline and Urolase laser fibres: is there any difference? World J Urol 1995; 13: 98-103
59. Heaton JP. Radiofrequency thermal ablation of the prostate: the TUNA technique. Tech Urol 1995; 1: 3-10
60. Costello AJ, Crowe HR, Jackson T, Street A. A randomised single institution study comparing laser prostatectomy and transurethral resection of the prostate. Ann Acad Med Singapore 1995; 24: 700-4
61. Keoghane SR, Cranston DW, Lawrence KC, Doll HA, Fellows GJ, Smith JC. The Oxford Laser Prostate Trial: a double-blind randomised controlled trial of contact vaporisation of the prostate against transurethral resection: preliminary results. Br J Urol 1996; 77: 382-5
62. Muschter R. Zellner M, Hessel S. Hofstetter A. Interstitial laser coagulation of the prostate: experiences in the treatment of benign prostatic hyperplasia. Prog Clin Biol Res 1994; 386: 521-7
63. Schafer W. Basic principles and clinical application of advanced analysis of bladder voiding function. Urol Clin North Am 1990; 17: 553-66
64. Schafer W, Rubben H, Noppeney R, Deutz F. Obstructed and unobstructed prostatic obstruction: a plea for urodynamic objectivation of bladder outflow obstruction by urodynamics. World J Urol 1989; 6: 198-203
65. Chapple CR. Correlation of symptomatology, urodynamics, morphology and size of the prostate in benign prostatic hyperplasia. Curr Opin Urol 1993; 3: 5-9
66. Anderson J, Grant J. Postoperative retention of urine: a prospective urodynamic study. BMJ 1991; 302: 894-6
67. Tan H, Hofner K. Kramer A, Thon W, Grunewald V, Jonas U. Benign prostatic hypertrophy (BPH): prostatic size, obstruction parameters, detrusor contractility and their interdependence. Neurourol Urodyn 1993; 12: 412-3